Squarepoint Ops LLC Astrazeneca PLC Put Options Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $14.7 Million - $16.7 Million	191,100 Added 79.2%	432,400 $33.7 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $7.48 Million - $9.05 Million	112,000 Added 86.62%	241,300 $18.8 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.56 Million - $1.78 Million	-25,600 Reduced 16.53%	129,300 $8.76 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $922,161 - $1.03 Million	14,900 Added 10.64%	154,900 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $32.1 Million - $34.8 Million	-458,500 Reduced 76.61%	140,000 $10 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $8.54 Million - $9.68 Million	135,200 Added 29.18%	598,500 $41.5 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $23 Million - $29.9 Million	424,000 Added 1078.88%	463,300 $31.4 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2.08 Million - $5.33 Million	39,300 New	39,300 $2.16 Million

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.